WORLD ANTI-MICROBIAL RESISTANCE CONGRESS, WASHINGTON DC, USA

Dr. Gitzinger will be speaking October 26th at 14:00 at the Congress in Washington, DC.

The Title: Composite endpoints – the way to FDA approval for non-traditional antibiotics requires new thinking around endpoints in clinical trials. Are composite endpoints a way forward?

The Agenda can be seen at this link. The Conference will be addressing 4 key areas:

• Antibiotic R&D
• Diagnostics
• Antimicrobial Stewardship
• Innovation Showcase

21ST-CENTURY DRUG DISCOVERY & DEVELOPMENT FOR GLOBAL HEALTH

Please join us at the Keystone Symposia in Berlin where Marc Gitzinger will be speaking. See http://www.keystonesymposia.org/18S3 for more details.

ESCMID/ASM CONFERENCE ON DRUG DEVELOPMENT

The ESCMID/ASM Conference on Drug Development to meet the chanllenge of antimicrobial resistance will be held in Lisbon, Portugal this year. Dr. Gitzinger will be attending.

The event information can be found here